Patent: 11,857,564
Summary for Patent: 11,857,564
| Title: | Hemostatic composition comprising an anion exchanger and a calcium salt |
| Abstract: | Provided are pharmaceutical compositions comprising an anion exchanger and a calcium salt; methods for inducing hemostasis at a site of bleeding by applying to the site of bleeding an effective amount of the compositions; and methods of preparation of the compositions. |
| Inventor(s): | Tamar AUERBACH-NEVO, Tali NEGREANU-GILBOA, Hadas ALPERIN, Israel Nur |
| Assignee: | Omrix Biopharmaceuticals Ltd |
| Application Number: | US15/840,329 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,857,564
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Omrix Biopharmaceuticals Ltd | CROSSEAL, EVICEL | fibrin sealant (human) | Spray | 125010 | March 21, 2003 | ⤷ Start Trial | 2037-12-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,857,564
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2017383546 | ⤷ Start Trial |
| Brazil | 112019012531 | ⤷ Start Trial |
| Canada | 3047529 | ⤷ Start Trial |
| China | 110121350 | ⤷ Start Trial |
| Colombia | 2019006822 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
